1426 - 1450 of 8,106
Number of results to display per page
TitleCreatorRelation Is Part Of
1426 Characterization of Reflex Tearing Induced by Light Stimuli in Relation to the Post-illumination Pupil ResponseShaobo Lei; Xingqiao Chen; Marija Zivcevska; Herbert Goltz; Agnes M. F. WongNANOS 2017: Poster Presentations
1427 Characterization of Serological Markers (ESR, CRP, Platelets) of Healed/Healing Arterial Injury and Biopsy Positive GCAVinay Kansal; Sangsu Han; James Farmer; Danah AlbreikiNANOS 2017: Poster Presentations
1428 Characterization of Subclinical Optic Nerve MRI Lesions in the N-Momentum TrialJeffrey Bennett; Friedemann Paul; John Chen; Michael Smith; Daniel Cimbora; Kristina Patterson; Bruce CreeNANOS Annual Meeting 2023: Scientific Platform Session III: https://novel.utah.edu/collection/NAM/toc/
1429 Characterization of Subclinical Optic Nerve MRI Lesions in the N-Momentum TrialJeffrey Bennett; Friedemann Paul; John Chen; Michael Smith; Daniel Cimbora; Kristina Patterson; Bruce CreeNANOS Annual Meeting 2023: Scientific Platform Session III: https://novel.utah.edu/collection/NAM/toc/
1430 Characterization of Subclinical Optic Nerve MRI Lesions in the N-Momentum TrialJeffrey Bennett; Friedemann Paul; John Chen; Michael Smith; Daniel Cimbora; Kristina Patterson; Bruce CreeNANOS Annual Meeting 2023: Scientific Platform Session III: https://novel.utah.edu/collection/NAM/toc/
1431 Characterization of Visual Pathway Abnormalities in Infants with Congenital Zika Syndrome Using CT and MRIAmanda Henderson; Thierry A. G. M. Huisman; Avner Meoded; Adriano Hazin; Vanessa van der Linden; William MayNANOS Annual Meeting 2019: Scientific Platform Presentations (Session 1)
1432 Characterization of Visual Pathway Abnormalities in Infants with Congenital Zika Syndrome Using CT and MRIAmanda Henderson; Thierry A. G. M. Huisman; Avner Meoded; Adriano Hazin; Vanessa van der Linden; William MayNANOS 2018: Scientific Platform I
1433 Characterization of Visual Pathway Abnormalities in Infants with Congenital Zika Syndrome Using CT and MRIAmanda Henderson; Thierry A. G. M. Huisman; Avner Meoded; Adriano Hazin; Vanessa van der Linden; William MayNANOS 2018: Scientific Platform I
1434 Characterization of VRDN-001, a High Affinity and Potent Anti-IGF-1R Inhibitory Antibody in Development for the Treatment of Thyroid Eye DiseaseVahe Bedian; Rachel Newell; Barrett KatzNANOS Annual Meeting 2022: Poster Session I: Orbital and Eyelid Disorders
1435 Characterizing Neurology and Ophthalmology Consults at a Large Tertiary Care HospitalMohamad Hassoun; Neena Cherayil; Shira Simon; Nicholas VolpeNANOS Annual Meeting 2023: Poster Session II: Neuro-Ophthalmic Practice
1436 Characterizing Structural Optic Nerve Head Changes in High ICP and Strategies to Address Image UncertaintyMegh D. Patel; Kiran Malhotra; Zainab Shirazi; Heather MossNANOS Annual Meeting 2018: Scientific Platform Presentations Session 3
1437 Characterizing Structural Optic Nerve Head Changes in High ICP and Strategies to Address Image UncertaintyMegh D. Patel; Kiran Malhotra; Zainab Shirazi; Heather MossNANOS Annual Meeting 2018: Scientific Platform Presentations Session 3
1438 Characterizing Structural Optic Nerve Head Changes in High ICP and Strategies to Address Image UncertaintyMegh D. Patel; Kiran Malhotra; Zainab Shirazi; Heather MossNANOS Annual Meeting 2018: Scientific Platform Presentations Session 3
1439 Characterizing the Pathobiological Mechanisms of Binocular Acuity Summation versus Inhibition in MS: Central Adaptation or Not?Sara S. Qureshi; Amy Conger; Darrel Conger; Ethan Meltzer; Peter Sguigna; Teresa Frohman; Elliot M. FrohmanNANOS 2014: Poster Presentations
1440 Charles Bonnet Syndrome and Periodic Alternating Nystagmus: Moving Visual HallucinationsNeda Minakaran; Lucy Barker; Gordon PlantNANOS 2012: Poster Presentations
1441 Charles Bonnet Syndrome in Mild and Moderate Visual LossRudrani Banik; Ana Victoria Carolina Reyes; Ilana B. Friedman
1442 Charles Bonnet Syndrome in Subsets of Low Vision PatientsRudrani Banik, MD; Ilana Friedman, MDNANOS 2004: Poster Presentations
1443 Charles Bonnet Syndrome Precipitated by Brimonidine Tartrate Eye DropsRobert L. Tomsak, MD, PhDNANOS 2002: Poster Presentations
1444 Check Point Inhibitor (CPI) Related Limbic EncephalitisEhtesham Khalid; James Mcguirk; Kassandra StubblefieldNANOS 2018: Poster Presentations
1445 Check Your Assumptions at the DoorMazin Elsarrag, Marielle Mahan, Shefali Sood, Lakshmi Shree Kulumani Mahadevan, Benjamin OsborneNANOS Annual Meeting 2023: Walsh Society Meeting Session I: "Adventureland": Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/
1446 Check Your Assumptions at the DoorMazin Elsarrag, Marielle Mahan, Shefali Sood, Lakshmi Shree Kulumani Mahadevan, Benjamin OsborneNANOS Annual Meeting 2023: Walsh Society Meeting Session I: "Adventureland": Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/
1447 Check Your Assumptions at the DoorMazin Elsarrag, Marielle Mahan, Shefali Sood, Lakshmi Shree Kulumani Mahadevan, Benjamin OsborneNANOS Annual Meeting 2023: Walsh Society Meeting Session I: "Adventureland": Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/
1448 Checking for a Relative Afferent Pupillary DefectH. Stanley Thompson, MDNANOS 1989: Pupil and Accomodation Symposium
1449 Checkpoint inhibitor associated orbital inflammation masquerading as ocular myasthenia gravis and thyroid eye diseaseMarisa Tieger; Eric Gaier; Sashank Prasad; Michael YoonNAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology
1450 Checkpoint Inhibitor-Associated Myositis of the Extraocular MusclesAriana Levin; Kathleen Digre; Bradley Katz; Alison Crum; Meagan Seay; Judith WarnerNANOS Annual Meeting 2020: Poster Session I: Clinical Highlights
1426 - 1450 of 8,106